Niklason Laura E 4
4 · Humacyte, Inc. · Filed Jun 17, 2024
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Niklason Laura E
DirectorPresident, CEO and Director
Transactions
- Award
Stock Options (right to buy)
2024-06-13+50,000→ 50,000 total(indirect: By Spouse)Exercise: $7.20Exp: 2034-06-13→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on June 13, 2025, after which 1/48 of the option will become exercisable on the 13th of each month through June 13, 2028.